This is the lowest level of holdings since December 31, 2018.

Tesla CEO Elon Musk tweeted that the company will make roughly 500,000 cars in 2019 after making zero cars in 2011. Reference Link

InterDigital, Inc. announced that LG Electronics has extended its license to use Hillcrest Labs' Freespace MotionEngine software in its Smart TVs for an additional three years. Hillcrest's Freespace MotionEngine is a pioneering software that enables the point-and-click and motion control features of the LG Magic Remote, which comes with LG's OLED, Super UHD and UHD 4K Smart TV product lines. LG began licensing Hillcrest's technology in 2010 and has since shipped tens of millions of TVs that work with Hillcrest's motion control technology. This latest agreement extends LG's license through the end of 2021.

Tesla CEO Elon Musk tweeted an image of 4,000 Tesla vehicles loading in San Francisco, California, to be transported to Europe. Reference Link

Hudbay Minerals announces increased mineral reserves and resources for its Lalor mine and nearby satellite deposits, and a new mine plan that includes the processing of gold and copper-gold ore at the company's New Britannia mill. Lalor annual gold production set to more than double from current levels once the New Britannia mill is refurbished with average annual production of approximately 140,000 ounces during the first five years at a sustaining cash cost, net of by-product credits, of $450 per ounce, positioning Lalor as one of the lowest-cost gold mines in Canada. Gold recoveries are estimated to increase to 93% at the New Britannia mill compared to 53% at the Stall mill.

Reports Q4 gold production 20.5K oz vs. 32.5K oz last year.

Calyxt and Agtegra Cooperative announced that Agtegra will offer distribution, storage and transportation services for Calyxt High Oleic Soybean to its customers. Agtegra is an innovative farmer owned grain and agronomy cooperative serving over 6,300 farmer members across North and South Dakota. They are the eighth largest ag retailer in the United States. As part of this agreement, Calyxt and Agtegra will work together to distribute Calyxt High Oleic Soybean seeds to the cooperative's farmer members in South Dakota and provide field services for proper placement and agronomic advice during the growing season. The collaboration will also include the storage and handling of Calyxt High Oleic Soybean grain at Agtegra under the Calyxt Soybean Identity Preserved Program, and logistics and transportation services for grain shipments. These services will build upon the existing Calyxt grower base for the Company's next product launch by collaborating with some of the Agtegra customers who also grow wheat, as well as elevators, to establish the Calyxt Wheat Identity Preserved supply chain.

Northrop Grumman has received notification of an unsolicited "mini-tender" offer by TRC Capital to purchase up to 500,000 shares, or approximately 0.29% of the outstanding common stock of the company as of January 28. TRC Capital's offer price of $274.25 per share in cash is approximately 4.44% less than the $286.98 closing price of the company's common stock on Feb. 15, the last trading day before the mini-tender offer commenced. The company does not endorse TRC Capital's mini-tender offer and recommends that shareholders do not tender their shares in response to the offer. The offer is at a price below the current market price for Northrop Grumman shares and is subject to various conditions. Mini-tender offers, such as this one by TRC Capital, seeking to acquire less than 5% of a company's outstanding shares, avoid many disclosure and procedural requirements of the SEC that apply to larger tender offers. As a result, these mini-tender offers do not provide investors with the same level of protection as provided by larger tender offers under U.S. federal securities laws.

Aphria announced that independent members of its Board of Directors consisting of Shlomo Bibas, John Herhalt, Tom Looney and Irwin Simon, unanimously approved the early termination and liquidation of a promissory note, option and other agreements related to the Company's previously announced divestment of all interests in Liberty Health Sciences, Inc. As detailed on September 6, 2018, the company entered into a share purchase agreement with a group of buyers, wherein it completed the sale of the shares making up 100% of its outstanding interest in Liberty, in exchange for a five-year promissory note due September 6, 2023, bearing interest at 12% per annum and in the amount of $59.1M. Aphria retained an irrevocable option to repurchase its shares in Liberty from the buyers for a period of up to five years, subject to the satisfaction of certain conditions.

Teva Pharmaceutical announced a settlement with the Federal Trade Commission that will resolve all outstanding litigation between the parties. Under the terms of the settlement, which is subject to court approval, the FTC will dismiss its claims against Teva and its affiliates in three outstanding cases, and the parties will modify certain terms in their 2015 consent decree. Teva will not pay any additional money to the FTC as part of this settlement. Originally entered in 2015 in FTC v. Cephalon, Inc., the consent decree provides clear guidance on the types of patent litigation settlements that are appropriate from the FTC's perspective. This clarity helps Teva manage the complex antitrust and other related issues inherent in the pharmaceutical business environment. The three outstanding cases that will be dismissed against Teva and its affiliates as a part of the settlement are FTC v. AbbVie (ABBV), FTC v. Actavis, Inc., and FTC v. Allergan PLC (AGN).